Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1979 Oct 1;150(4):862–877. doi: 10.1084/jem.150.4.862

Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein

PMCID: PMC2185669  PMID: 390084

Abstract

We tested the ability of pepsin-extracted, highly purified M protein to induce type-specific immunity in experimental animals and humans. M protein was prepared from limited peptic digests of whole group A type 24 streptococci and was purified to chemical homogeneity as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, quantitative amino acid analysis, and Edman degradation. For vaccination, the lyophilized M24 protein preparation (pep M24) was precipitated in aluminum hydroxide. When injected into laboratory animals, alum- precipitated pep M24 produced type-specific protective antibodies and was free of non-type-specific immunoreactivity. In man, skin tests with 1-microgram doses of pep M24 were negative in all 37 adults tested. 12 adult human volunteers received two-four subcutaneous injections of 100- 200 micrograms of alum-precipitated pep M24 at intervals of at least 2 wk. The immune response to pep M24 was measured by a variety of assays designed to detect (a) type-specific humoral antibodies (opsonophagocytic, long chain, and mouse protection tests); (b) total humoral antibodies (complement fixation and enzyme-linked immunosorbent assay); (c) cellular immunity (skin tests); and (d) heart cross- reactive antibodies (immunofluorescence). Type-specific opsonic antibodies developed in 10 of the 12 vaccinees, and positive delayed- type skin tests developed in 11. Immune sera from two of the vaccinees were effective in mouse-protection tests against challenge with M24 but not M6 streptococci. None of the volunteers developed heart-reactive antibodies or antibodies to non-type-specific M protein antigens. Alum- precipitated pep M24 was well-tolerated in man, and no serious local or systemic reactions were observed. Thus, pep M24 induces type-specific, protective antibodies in doses that are well-tolerated in man.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askenase P. W., Atwood J. E. Basophils in tuberculin and "Jones-Mote" delayed reactions of humans. J Clin Invest. 1976 Nov;58(5):1145–1154. doi: 10.1172/JCI108567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beachey E. H., Alberti H., Stollerman G. H. Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol. 1969 Jan;102(1):42–52. [PubMed] [Google Scholar]
  3. Beachey E. H., Campbell G. L., Ofek I. Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun. 1974 May;9(5):891–896. doi: 10.1128/iai.9.5.891-896.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beachey E. H., Chiang E. Y., Seyer J. M., Kang A. H., Chiang T. M., Stollerman G. H. Separation of the type specific M protein from toxic cross reactive antigens of group A streptococci. Trans Assoc Am Physicians. 1977;90:390–400. [PubMed] [Google Scholar]
  5. Beachey E. H., Ofek I., Bismo A. L. Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol. 1973 Nov;111(5):1361–1366. [PubMed] [Google Scholar]
  6. Beachey E. H., Seyer J. M., Kang A. H. Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3163–3167. doi: 10.1073/pnas.75.7.3163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beachey E. H., Stollerman G. H., Chiang E. Y., Chiang T. M., Seyer J. M., Kang A. H. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med. 1977 Jun 1;145(6):1469–1483. doi: 10.1084/jem.145.6.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Beachey E. H., Stollerman G. H. Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest. 1973 Oct;52(10):2563–2570. doi: 10.1172/JCI107448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Beachey E. H., Stollerman G. H. Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med. 1971 Aug 1;134(2):351–365. doi: 10.1084/jem.134.2.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cunningham M., Beachey E. H. Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol. 1975 Oct;115(4):1002–1006. [PubMed] [Google Scholar]
  11. D'Alessandri R., Plotkin G., Kluge R. M., Wittner M. K., Fox E. N., Dorfman A., Waldman R. H. Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A Streptococcus. J Infect Dis. 1978 Dec;138(6):712–718. doi: 10.1093/infdis/138.6.712. [DOI] [PubMed] [Google Scholar]
  12. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972 Jul;109(1):129–135. [PubMed] [Google Scholar]
  13. Fischetti V. A. Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule. J Exp Med. 1977 Oct 1;146(4):1108–1123. doi: 10.1084/jem.146.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fox E. N., Pachman L. M., Wittner M. K., Dorfman A. Primary immunization of infants and children with group A streptococcal M protein. J Infect Dis. 1969 Nov;120(5):598–604. doi: 10.1093/infdis/120.5.598. [DOI] [PubMed] [Google Scholar]
  15. Fox E. N., Waldman R. H., Wittner M. K., Mauceri A. A., Dorfman A. Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers. J Clin Invest. 1973 Aug;52(8):1885–1892. doi: 10.1172/JCI107372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fox E. N., Wittner M. K., Dorfman A. Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans. J Exp Med. 1966 Dec 1;124(6):1135–1151. doi: 10.1084/jem.124.6.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hirst G. K., Lancefield R. C. ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1939 Feb 28;69(3):425–445. doi: 10.1084/jem.69.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KAPLAN M. H. IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS. I. PROPERTIES OF AN ANTIGEN IN CERTAIN STRAINS OF GROUP A STREPTOCOCCI EXHIBITING AN IMMUNOLOGIC CROSS-REACTION WITH HUMAN HEART TISSUE. J Immunol. 1963 Apr;90:595–606. [PubMed] [Google Scholar]
  19. Kang A. H. Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing -hydroxylysinonorleucine. Biochemistry. 1972 May 9;11(10):1828–1835. doi: 10.1021/bi00760a015. [DOI] [PubMed] [Google Scholar]
  20. LANCEFIELD R. C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed] [Google Scholar]
  21. LANCEFIELD R. C., PERLMANN G. E. Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J Exp Med. 1952 Jul;96(1):71–82. doi: 10.1084/jem.96.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  23. Lancefield R. C. THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : II. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE PROTEIN FRACTIONS. J Exp Med. 1928 Feb 29;47(3):469–480. doi: 10.1084/jem.47.3.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Massell B. F., Michael J. G., Amezcua J., Siner M. Secondary and apparent primary antibody responses after group A streptococcal vaccination of 21 children. Appl Microbiol. 1968 Mar;16(3):509–518. doi: 10.1128/am.16.3.509-518.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. POTTER E. V., STOLLERMAN G. H., SIEGEL A. C. Recall of type specific antibodies in man by injections of streptococcal cell walls. J Clin Invest. 1962 Feb;41:301–310. doi: 10.1172/JCI104483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Russell H., Facklam R. R., Edwards L. R. Enzyme-linked immunosorbent assay for streptococcal M protein antibodies. J Clin Microbiol. 1976 May;3(5):501–505. doi: 10.1128/jcm.3.5.501-505.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. SCHMIDT W. C. Type-specific antibody formation in man following injection of streptococcal M protein. J Infect Dis. 1960 May-Jun;106:250–255. doi: 10.1093/infdis/106.3.250. [DOI] [PubMed] [Google Scholar]
  28. STOLLERMAN G. H., SIEGEL A. C., JOHNSON E. E. Evaluation of the "long chain reaction" as a means for detecting type-specific antibody to group a streptococci in human sera. J Exp Med. 1959 Dec 1;110:887–897. doi: 10.1084/jem.110.6.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stollerman G. H. Prospects for a vaccine against group A streptococci: the problem of the immunology of M proteins. Arthritis Rheum. 1967 Jun;10(3):245–255. doi: 10.1002/art.1780100311. [DOI] [PubMed] [Google Scholar]
  30. Stollerman G. H. The relative rheumatogenicity of strains of group A streptococci. Mod Concepts Cardiovasc Dis. 1975 Jul;44(7):35–40. [PubMed] [Google Scholar]
  31. Taranta A. Factors influencing recurrent rheumatic fever. Annu Rev Med. 1967;18:159–172. doi: 10.1146/annurev.me.18.020167.001111. [DOI] [PubMed] [Google Scholar]
  32. Vosti K. L. Characterization of a non-type-specific antigen(s) associated with group A streptococcal type 12 M protein. Infect Immun. 1975 Jun;11(6):1300–1306. doi: 10.1128/iai.11.6.1300-1305.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. WOLFE C. K., Jr, HAYASHI J. A., WALSH G., BARKULIS S. S. Type-specific antibody response in man to injections of cell walls and M protein from group A, type 14 streptococci. J Lab Clin Med. 1963 Mar;61:459–468. [PubMed] [Google Scholar]
  34. Wannamaker L. W. The chain that links the heart to the throat. Circulation. 1973 Jul;48(1):9–18. doi: 10.1161/01.cir.48.1.9. [DOI] [PubMed] [Google Scholar]
  35. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  36. Widdowson J. P., Maxted W. R., Pinney A. M. An M-associated protein antigen (MAP) of group A streptococci. J Hyg (Lond) 1971 Dec;69(4):553–564. doi: 10.1017/s0022172400021823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Zabriskie J. B., Freimer E. H. An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med. 1966 Oct 1;124(4):661–678. doi: 10.1084/jem.124.4.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. van de Rijn I., Zabriskie J. B., McCarty M. Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med. 1977 Aug 1;146(2):579–599. doi: 10.1084/jem.146.2.579. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES